https://www.prnewswire.com/news-releases/accord-healthcare-us-relaunches-tadalafil-tablets-broadening-availability-of-approved-dosage-strengths-302758227.html
Accord Healthcare US Relaunches Tadalafil Tablets, Broadening Availability of Approved Dosage...
/PRNewswire/ -- Accord Healthcare, Inc., a leading generic pharmaceutical company, committed to improving access to affordable medicines, today announced the...
accord healthcaretadalafil tabletsus
https://www.directrelief.org/partnership/accord-healthcare/
Accord Healthcare | Partnerships | Direct Relief
22 Million Sri Lankans Lose Their Access to Medicine
accord healthcarepartnershipsdirectrelief
https://www.prnewswire.com/news-releases/accord-healthcare-adds-pemetrexed-injection-to-generic-chemotherapy-drug-portfolio-301622368.html
Accord Healthcare Adds Pemetrexed Injection to Generic Chemotherapy Drug Portfolio
/PRNewswire/ -- Accord Healthcare, Inc., a leading generic pharmaceutical company, has added Pemetrexed Injection (Solution) to its line of chemotherapy...
accord healthcarepemetrexed injectionchemotherapy drugaddsgeneric
https://www.prnewswire.com/news-releases/accord-healthcare-launches-generic-drug-for-treating-brain-tumors--blood-cancers-301610354.html
Accord Healthcare Launches Generic Drug for Treating Brain Tumors & Blood Cancers
/PRNewswire/ -- Accord Healthcare, Inc., a leading generic pharmaceutical company, has added Carmustine to its line of chemotherapy drugs. The drug is...
accord healthcaregeneric drugbrain tumorslaunches
https://www.prnewswire.com/news-releases/accord-healthcare-us-reintroduces-hydrochlorothiazide-tablets-expanding-access-across-all-three-strengths-302730673.html
Accord Healthcare US Reintroduces Hydrochlorothiazide Tablets, Expanding Access Across All Three...
/PRNewswire/ -- Accord Healthcare, Inc., a leading generic pharmaceutical company, committed to improving access to affordable medicines, today announced the...
accord healthcareexpanding accessushydrochlorothiazide
https://www.prnewswire.com/news-releases/accord-healthcare-adds-generic-drug-for-use-in-treating-leukemia-and-non-hodgkins-lymphoma-301696609.html?tc=eml_cleartime
Accord Healthcare Adds Generic Drug for Use in Treating Leukemia and Non-Hodgkin's Lymphoma
/PRNewswire/ -- Accord Healthcare, Inc., a leading generic pharmaceutical company, has added Bendamustine Lyo. Injection to its line of chemotherapy drugs....